SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 30th, 2023 • BioLineRx Ltd. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of August 27, 2023, by and between BioLineRx Ltd., a company organized under the laws of the State of Israel (the “Company”), Hong Seng Technology Limited, a company organized under the laws of Hong Kong (the “Purchaser”), and Guangzhou Gloria Biosciences Co., Ltd., a company organized under the laws of the People’s Republic of China (the “Gloria” and together with the Purchaser, the “Purchaser Parties”).
License AgreementLicense Agreement • August 30th, 2023 • BioLineRx Ltd. • Pharmaceutical preparations • England and Wales
This License Agreement is entered into as of 27 August, 2023 (the “Execution Date”), by and among BioLineRx, Ltd., a company organized under the laws of the State of Israel, having a place of business at Modi’in Technology Park, 2 HaMa’ayan Street, Modi’in, 7177871, Israel, together with its Affiliates (“BioLine”); and Guangzhou Gloria Biosciences Co., Ltd., a company organized under the laws of the PRC, having a place of business at 3rd Floor, Building No. 2, 1 Nanxiang Third Road, Huangpu District, Guangzhou City, PRC (“Gloria Biosciences”); and Hong Seng Technology Limited, a company organized under the laws of the Special Administrative Region of Hong Kong, having a place of business at 14/F, Chun Wo Commercial, Centre, 25 Wing Wo Street, Central, Hong Kong (“HS Tech”). Each of BioLine, Gloria Biosciences and HS Tech may be referred to herein as a “Party” and together as the “Parties.”
